Status:
WITHDRAWN
Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45
Lead Sponsor:
NSABP Foundation Inc
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Breast Cancer
Fatigue
Eligibility:
FEMALE
Brief Summary
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to fatigue. PURPOSE: This ...
Detailed Description
OBJECTIVES: * To collect serial blood specimens at each time point that quality of life and patient-reported outcome assessments are performed in women with residual invasive breast cancer concurrent...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Diagnosis of residual invasive breast cancer
- Stage II, IIIA, or IIIB disease
- HER2/neu-negative disease
- Randomized to receive either sunitinib malate or placebo on clinical trial NSABP-B-45
- Has not started therapy on clinical trial NSABP-B-45
- Has completed baseline Behavioral and Health Outcome questionnaires on clinical trial NSABP-B-45
- Hormone-receptor status not specified
- PATIENT CHARACTERISTICS:
- Menopausal status not specified
- PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Exclusion
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00914043
End Date
June 1 2010
Last Update
January 11 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.